Table 1.

IC50 values (nM) of mitoxantrone and imatinib determined by FDA/PI assay in K562, K562/BCRP, and K562/BCRP-MX10 cells




K562 wild type

K562/BCRP

K562/BCRP-MX10
Mitoxantrone   1.52 ± 0.38 (1.0)   8.35 ± 1.6* (5.5)   10.9 ± 3.8* (7.2)  
Imatinib
 
44.4 ± 5.4 (1.0)
 
58.7 ± 9.4 (1.3)
 
89.3 ± 4.7 (2.0)
 



K562 wild type

K562/BCRP

K562/BCRP-MX10
Mitoxantrone   1.52 ± 0.38 (1.0)   8.35 ± 1.6* (5.5)   10.9 ± 3.8* (7.2)  
Imatinib
 
44.4 ± 5.4 (1.0)
 
58.7 ± 9.4 (1.3)
 
89.3 ± 4.7 (2.0)
 

Each value represents the mean value ± SEM (n = 4). Relative resistance is shown in parentheses as the ration of the IC50 of K562-expressing BCRP over the IC50 of K562 wild type.

*

Two-sample t test; P < .05.

Two-sample t test; P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal